Home
Resources
Diseases
COVID-19
Hepatitis B
Human papillomavirus (HPV)
Malaria
Measles
Mpox
Pneumococcal disease
RSV (Respiratory syncytial virus)
Compendium
Hexavalent vaccines
HPV vaccines
Malaria vaccines
PCV vaccines
RSV vaccines
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (40)
NITAG documentation (1632)
Reports (61)
SAGE documentation (226)
Scientific publications (120)
Systematic reviews (SYSVAC) (3034)
Regions
Africa (294)
Americas (787)
Eastern Mediterranean (58)
Europe (736)
Global (1)
South-East Asia (82)
Western Pacific (212)
Diseases
Chikungunya (12)
Cholera (35)
COVID-19 (1568)
Cytomegalovirus (1)
Dengue (42)
Diphtheria (89)
Ebola (18)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (71)
Hepatitis A (69)
Hepatitis B (168)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (75)
HIV / AIDS (10)
Human papillomavirus (HPV) (526)
Influenza (623)
Japanese encephalitis (34)
Lyme disease, Borreliosis (2)
Malaria (31)
Measles (143)
Meningococcal disease (153)
Moraxella catarrhalis (1)
Mpox (56)
Mumps (49)
Pertussis (120)
Pneumococcal disease (299)
Poliomyelitis (93)
Q fever (1)
Rabies (33)
Rotavirus (121)
RSV (Respiratory syncytial virus) (66)
Rubella (69)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (71)
Tick-borne encephalitis (13)
Tuberculosis (83)
Typhoid (31)
Varicella (76)
Yellow fever (44)
Zika (1)
Show more
5113 results found
2022
∙
NACI, Public Health Agency of Canada
Recommended use of palivizumab to reduce complications of respiratory syncytial virus infection in infants
2022
∙
Haute Autorité de Santé
Revision of the rotavirus vaccine strategy and the place of Rotarix and RotaTeq vaccines
2022
∙
ACIP
Safety & Immunogenicity of a 3-Antigen Hepatitis B Vaccine, PreHevbrio™
2022
∙
STIKO
Scientific justification of the STIKO for the recommendation of the 2nd COVID-19 booster vaccination with an mRNA vaccine for groups of people who are particularly at risk of health or are exposed
2022
Second booster vaccination against COVID-19
2022
∙
SAGE
Statistical report on the results of the RTS,S/AS01 Malaria Vaccine Pilot Evaluation 24 months after the vaccine was introduced (September 2021, v1.2)
2022
∙
STIKO
STIKO resolution on the 17th update of the COVID-19 vaccination recommendation
2022
∙
NACI
Summary of NACI advice on vaccination with COVID-19 vaccines following myocarditis (with or without pericarditis)
2022
∙
Haute Autorité de Santé
The French NITAG recommends whooping cough vaccine in pregnant women
2022
∙
Haute Autorité de Santé
the French public health agency on monkeypox vaccination
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register